Edlund, P., Ahlgren, J., Bjerre, K., Andersson, M., Bergh, J., Mouridsen, H., … Blomqvist, C. (2011). Dose-tailoring of FEC adjuvant chemotherapy based on leukopenia is feasible and well tolerated. Toxicity and dose intensity in the Scandinavian Breast Group phase 3 adjuvant Trial SBG 2000-1. Acta Oncologica, 50(3), 329–337. https://doi.org/10.3109/0284186X.2011.554435